Ultragenyx Pharmaceutical Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
RARE on Nasdaq
Industry
Pharmaceutical Preparations
Location
60 Leveroni Court, Novato, California

Insiders trading volume in the past year

Ultragenyx Pharmaceutical Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Emil D. Kakkis President & CEO, Director $156M -$6.51M -4.01% Sep 3, 2024
Thomas Richard Kassberg Cbo & Evp $12.6M -$1.94M -13.3% Mar 11, 2024
Howard Horn Chief Financial Officer $5.36M Mar 1, 2024
John Richard Pinion EVP, Chief Quality Operations Officer $4.8M -$224K -4.47% Mar 1, 2024
Dennis Karl Huang EVP, Chief Technical Operations Officer $4.46M Mar 1, 2024
Erik Harris EVP & Chief Commercial Officer $3.61M -$256K -6.63% Mar 1, 2024
Karah Parschauer EVP and Chief Legal Officer $2.61M -$643K -19.8% Jun 12, 2024
Theodore Alan Huizenga SVP, Chief Accounting Officer $2.33M -$23.4K -0.99% Sep 3, 2024
Eric Crombez EVP and Chief Medical Officer $2.11M -$88.3K -4.01% May 2, 2024
William Aliski Director $1.62M Jun 24, 2021
Mardi Dier CFO & Executive Vice President $1.4M Oct 14, 2022
Daniel G. Welch Director $1.21M Jun 18, 2024
Michael Narachi Director $1.21M Jun 18, 2024
Deborah Dunsire Director $1.13M Jun 18, 2024
Camille L. Bedrosian EVP and Chief Medical Officer $981K Mar 1, 2023
Matthew K. Fust Director $909K -$620K -40.6% Jun 18, 2024
Shehnaaz Suliman Director $909K Jun 18, 2024
Amrit Ray Director $793K Jun 18, 2024
(Corsee) Sanders Corazon Director $492K -$95.3K -16.2% Jul 2, 2024
Lars Ekman Director $373K Jun 24, 2022

Recent Insider Transactions by Companies or Individuals for Ultragenyx Pharmaceutical Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.